Ingredient or product comparison
GHK-Cu with Alcohol Safety: Full Comparison
Concurrent systemic use (oral alcohol + subcutaneous GHK-Cu) Blood alcohol 0.08–0.15% No direct pharmacokinetic interaction Separate metabolic pathways. Alcohol via ADH/ALDH, peptide via plasma peptidases Immediate (no interaction) Safe from interaction standp
This source-based comparison does not add ratings or recommend a winner.
- Concurrent systemic use (oral alcohol + subcutaneous GHK-Cu)
- Blood alcohol 0.08–0.15%
- No direct pharmacokinetic interaction
- Separate metabolic pathways. Alcohol via ADH/ALDH, peptide via plasma peptidases
- Immediate (no interaction)
- Safe from interaction standpoint; alcohol's inflammatory effects may confound regenerative studies
- Bacteriostatic water (standard)
- 0.9% benzyl alcohol
- No destabilisation
- Concentration below copper dissociation threshold
- 28 days stable at 2–8°C
- Recommended standard for reconstitution
- High-ethanol bacteriostatic solution
- 10–20% ethanol
- Moderate to severe copper dissociation
- Reduced dielectric constant + solvation disruption
- 48–72 hours
- Not recommended. Use 0.9% benzyl alcohol formulations only
- Residual isopropanol from sterilisation
- 5–8% (localised)
- Measurable copper dissociation in first draw
- Inadequate evaporation before reconstitution
- 24–72 hours
- Preventable error. Allow 60-second evaporation post-sterilisation
- Ethanol storage vapour contamination
- 2–4% (accumulated)
- Slow cumulative destabilisation
- Vapour-phase ethanol absorption through non-sealed stoppers
- Weeks to months
- Use crimp-sealed or PTFE-lined vials in shared refrigerators